For current publications please use the following link to search the PubMed web site for recent articles published by the Division of Endocrinology faculty.

www.ncbi.nlm.nih.gov/Pubmed
*Note: this will open a new window. Simply close the window to return here.

Cohen, Robert
Cohen RM, Lecaire T.J. Lindsell CJ, Smith EP, D'Alessio DJ. The Relationship of Prospective Glycated Hemoglobin to Glycated Serum Proteins in Incident Diabetic Retinopathy: Implications of the Glycation Gap for Mechanism of Risk Prediction Diabetes Care, in press, 2007.

Cohen, R.M. A1C: does one size fit all? (Invited Editorial) Diabetes Care 30: 2756-2758, 2007.

Gerstein HC, Riddle MC, Kendall DM, Cohen RM, Goland R, Feinglos MN, Kirk JK, Hamilton BP, Ismail-Beigi F, Feeney P, ACCORD Study Group. Glycemia Treatment Strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial 99 (issue 12 supplement): S34-S43,2007.

Robert M Cohen, MD, Harold Snieder, PhD, Christopher J Lindsell, PhD, Huriya Beyan, PhD, Mohammed I Hawa, BSc, Stuart Blinko, PhD, Raymond Edwards, PhD and Richard DG Leslie, MD Evidence for Independent Heritability of the Glycosylation Gap Fraction of HbA1c in Non-Diabetic Twins. Diabetes Care 29: 1739-43, 2006.

Dolan LM, Bean J, D'Alessio D, Cohen RM, Morrison JA, Goodman E, Daniels SR. The frequency of abnormal carbohydrate metabolism and diabetes in a population based screening of adolescents. J Pediatrics 146:751-758, 2005.

D'Alessio, David
Zhang R, Packard BA, Tauchi M, D'Alessio DA, Herman JP. Glucocorticoid regulation of preproglucagon transcription and RNA stability during stress. Proc Natl Acad Sci U S A., 2009; 106:5913-8.

D'Alessio DA, Denney AM, Hermiller LM, Prigeon RL, Martin JM, Tharp WG, Saylan ML, He YL, Dunning BE, Foley JE, Pratley RE. Treatment with the DPP-4 inhibitor Vildagliptin improves fasting islet-cell function in subjects with Type 2 diabetes. J Clin Endocrinol Metab, 2009; 94:81-8.

Brehm BJ, Lattin BL, Summer SS, Boback JA, Gilchrist GM, Jandacek RJ, D'Alessio DA. One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes. Diabetes Care, 2009; 32:215-20.

Sandoval DA, Bagnol D, Woods SC, D'Alessio DA, Seeley RJ. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake. Diabetes. 2008; 57:2046-54.

Salehi M, Vahl TP, D'Alessio DA. Regulation of islet hormone release and gastric emptying by endogenous GLP-1 following glucose ingestion. J Clin Endocrinol Metab, 2008; 93:4909-16.

Diab, Dima
Diab D, Faiman C, Siperstein A, Grossman W, Rabinowitz L, Hamrahian A. A Virilizing Ovarian Leydig Cell Tumor in a Woman with Subclinical Cushing Syndrome. Endocrine Practice 2008;14(3):358-361.

Hoogwerf B, Doshi K, Diab D. Pramlintide, the Synthetic Analogue of Amylin: Physiology, Pathophysiology and Effects on Glycemic Control, Body Weight and Selected Biomarkers of Vascular Risk. Vascular Health and Risk Management 2008;4(2):355-362.

Diab D, Faiman C, Siperstein A, Zhou M, Zimmerman R. Virilizing Adrenal Ganglioneuroma in a Woman with Subclinical Cushing Syndrome. Endocrine Practice 2008;14(5):584-587.

Diab D, Yerian L, Schauer P, Kashyap S, Lopez R, Hazen S, Feldstein A. Cytokeratin 18 Fragment Levels as a Noninvasive Biomarker for Nonalcoholic Steatohepatitis in Bariatric Surgery Patients. Clinical Gastroenterology and Hepatology (in press).

Diab D, Hamrahian A. Detection and Treatment of Benign and Malignant Pituitary Diseases. Molecular Pathology of Endocrine Diseases (in press).

Falciglia, Mercedes
Sharma S; Canos M; Falciglia M: Optimizing Perioperative Glycemic Control. International Anesthesiology Clinics. (In press.)

Falciglia M; Freyberg RW; Almenoff PL; D Alessio DA; Render ML: Hyperglycemia-Related Mortality in Critically Ill Patients Varies with Admission Diagnosis. Critical Care Medicine. (In press.)

Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN: Molecular Testing for Mutations in Improving the Fine Needle Aspiration Diagnosis of Thyroid Nodules. J Clin Endocrinol Metab. Jun 2009;94(6):2092-2098.

Falciglia M: Causes and consequences of hyperglycemia in critical illness. Curr Opin Clin Nutr Metab Care. 2007;10:498-503.

Falciglia M: Intensive insulin therapy for the critically ill hospitalized patient-do the benefits outweigh the risks? Nat Clin Pract Endocrinol Metab. 2007;3:386-387.

Goldenberg, Nadia
Goldenberg N, Glueck C. Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk. Vasc Health Risk Manag. 2009;5(1):369-76. Review.

Surya S, Horowitz JF, Goldenberg N, Sakharova A, Harber M, Cornford AS, Symons K, Barkan AL. The pattern of GH delivery to peripheral tissues determines IGF-1 and lipolytic responses in obese subjects. J Clin Endocrinol Metab. 2009 May 26.

Glueck CJ, Morrison JA, Goldenberg N, Wang P. Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Metabolism. 2009 May;58(5):714-21.

Goldenberg N, Glueck CJ. Is pharmacogenomics our future? Metformin, ovulation and polymorphism of the STK11 gene in polycystic ovary syndrome.Pharmacogenomics. 2008 Aug;9(8):1163-5.

Goldenberg N, Racine MS, Thomas P, Degnan B, Chandler W, Barkan A.Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant. J Clin Endocrinol Metab. 2008 Aug;93(8):2953-6. Epub 2008 May 20

Jacobson, Eric
Jacobson EM, Concepcion E, Oashi, T, Tomer Y: (2005). A Graves Disease Associated Kozak SNP Enhances the Efficiency of CD40 Gene Translation: A Case for Translational Pathophysiology. Endocrinology. 146: 2684-2691.

Kershonsky SM, Jung DW, Kang TW, Walsh DP, Moon HS, Jo H, Jacobson EM, Shetty V., Neubert TA, Chang YT: (2003). Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc. 125(39):11804-5.

Moon HS, Jacobson EM, Khersonsky SM, Luzung MR, Walsh DP, Xiong W, Lee JW, Parikh PB, Lam JC, Kang TW, Rosania GR, Schier AF, Chang YT: (2002). A novel microtubule destabilizing entity from orthogonal synthesis of triazine library and zebrafish embryo screening. J Am Chem Soc.124(39):11608-9.

Scully KM, Jacobson EM, Jepsen K, Lunyak V, Viadiu H, Carriere C, Rose DW, Hooshmand F, Aggarwal AK, Rosenfeld MG: (2000). Allosteric effects of Pit-1 DNA sites on long-term repression in cell type specification. Science. 290(5494):1127-31.

Jacobson EM, Li P, Leon-del-Rio A, Rosenfeld MG, Aggarwal AK: (1997). Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility. Genes and Development. 11(2):198-212.

Ramlo-Halsted, Barbara
Ramlo-Halsted BA, Edelman SV, "The Natural History of Type 2 Diabetes: Practical Points to Consider in Developing Prevention and Treatment Strategies. Clinical Diabetes. 2000. Spring;18(2):80-85.

Cohen RM, Ramlo-Halsted BA. How Do the New Insulin Secretagogues Compare? Diabetes Care 25:1472-3, 2002.

Salehi, Marzieh
Salehi M, Vahl T, D'Alessio D. Regulation of islet hormone release and gastric emptying by endogenous GLP-1 following glucose ingestion. J Clin Endocrinol Metab, 93 (12): 4909-4916; 2008.

Salehi M, Aulinger B, D'Alessio D. Targeting ²-cell mass in Type 2 diabetes: Promise and limitations of new drugs based on incretins. Endocr Rev, 29(3):367-79; 2008.

D'Alessio D, Aulinger B, Salehi M. The incretin effect: Regulation of insulin secretion and glucose tolerance by GI hormones. In: Greenbaum and Harrison eds. Diabetes: Translating research into practice. Informa Healthcare, 5th edition; 2008.

Salehi M, Glueck CJ. Polycystic Ovary Syndrome. In: Mohler ER, Townsend RR eds. Advanced therapy in hypertension and vascular disease. Ontario: BC Decker; 2006.

Salehi M, D'Alessio DA. New therapies for type 2 diabetes based on glucagon-like peptide 1. Cleve Clin J Med.73:382-9; 2006.

Sharma, Sona
Sharma S; Canos M; Falciglia M: Optimizing Perioperative Glycemic Control. International Anesthesiology Clinics. In press.

Tong, Jenny
Tong J, Fujimoto WY, Kahn SE, McNeely MJ, Weigle DS, Boyko EJ: Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-up in non-diabetic Japanese-Americans. Diabetes 2005; 54(4):985-990.

Tong J, Utzschneider KM, Carr DB, Hull RL, Zraika S, Udayasankar J, Gerchman F, Knopp RH, Kahn SE: Parasympathetic Innervation May Mediate the Effect of Age and Gender on Body Fat Distribution in Humans. Diabetologia 2007; 50(2):439-42.

Utzschneider KM, Tong J, Montgomery B, Udayasankar J, Gerchman F, Marcovina SM, Watson CE, Ligueros-Saylan MA, Foley JE, Holst JJ, Deacon CF, Kahn SE: The dipeptidyl peptidase-4 inhibitor vildagliptin improves insulin sensitivity and ²-cell function in subjects with impaired fasting glucose. Diabetes Care 2007, Oct 1.

Tong J, Boyko EJ, McNeely MJ, Hayashi T, Utzschneider KM, Carr DB, Hull R, Wallace TM, Zraika S, Shofer JB, Leonetti DL, Fujimoto WY, Kahn SE: Intra-abdominal Fat Predicts the Future Development of the Metabolic Syndrome in Japanese Americans. Diabetologia 2007; 50(6):1156-60.

Wallace TM*, Utzschneider KM*, Tong J*, Carr DB, Zraika S, Bankson DD, Knopp RH, Kahn SE: Relationship of Liver Enzymes to Insulin Sensitivity and Intra-abdominal Fat. Diabetes Care 2007, July 31. Diabetes Care 2007; 30(10):2673-78. *Authors with equal contribution to manuscript.

Watts, Nelson
Watts NB, Miller PD, Kohlmeier LA et al. Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment. J Bone Miner Res 2009;24:1125-1131

McTiernan A, Wactawski-Wende J, Rodabaugh RJ, Watts NB et al. Low-fat, increased fruit, vegetable and grain dietary pattern and bone mineral density: the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr 2009;89:1864-1876.

Miller PD, Delmas PD, Lindsay R, Watts NB et al. Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab 2008;93:3785-3793.

Watts NB, Chines A, Olszynski WP et al. Fracture risk remains reduced one year after discontinuation of risedronate. Osteoporos Int 2007; 19:365-372.

Robbins J, Argaki A, Kooperberg C, Watts N et al. Factors associated with 5-year risk of hip fracture in postmenopausal women. JAMA 2007;298:2389-2398.